**Core Concept**
Splenectomy is considered a therapeutic option for patients with idiopathic thrombocytopenic purpura (ITP) who do not respond to medical therapy. The underlying principle is the spleen's role in the pathogenesis of ITP, where it acts as a reservoir for autoreactive T and B cells, leading to the production of antibodies against platelets.

**Why the Correct Answer is Right**
The correct answer is related to the removal of the spleen's destructive effect on platelets. In ITP, platelets are destroyed by splenic macrophages, which recognize platelets as foreign due to antibody coating. By removing the spleen, the primary site of platelet destruction is eliminated, allowing platelet count to increase. This is particularly beneficial in patients who do not respond to first-line treatments such as corticosteroids.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because it does not provide a direct link between splenectomy and the pathogenesis of ITP. While it may be a risk factor for thrombocytopenia, it is not a relevant evidence for the benefit of splenectomy in ITP.
* **Option B:** This option is incorrect because it is a general statement about the management of ITP, but it does not specifically relate to the benefit of splenectomy.
* **Option C:** This option is incorrect because it is a treatment option for ITP, but it is not a direct evidence of the benefit of splenectomy.

**Clinical Pearl / High-Yield Fact**
Splenectomy is generally considered a last resort for patients with ITP due to the risks associated with the surgery, including infection and thrombosis. Therefore, it is essential to carefully evaluate patients for splenectomy, considering factors such as the severity of thrombocytopenia, the presence of bleeding complications, and the failure of medical therapy.

**Correct Answer: B. Increased platelet survival**